INMB — Inmune Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Inmune Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	22	74.8	52.2	35.8	20.9
Net Total Receivables	1.8	5.5	8.46	2.44	1.41
Prepaid Expenses
Total Current Assets	24	82.6	64.7	39.9	22.7
Net Property, Plant And Equipment	0.156	0.726	0.507	0.414	0.307
Net Intangible Assets
Other Long Term Assets
Total Assets	40.7	99.9	81.8	57	39.6
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.78	4.36	10.9	18.5	7.22
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.9	19.7	21.7	18.9	7.46
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.8	80.2	60.1	38.1	32.1
Total Liabilities & Shareholders' Equity	40.7	99.9	81.8	57	39.6
Total Common Shares Outstanding